drugset
drugset / Trial / NCT07028749

Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol

NCT07028749 ↗

Phase 2 Active not recruiting 216 enrolled Marea Therapeutics The TIMI Study Group · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective of the study is to evaluate the effect of MAR001 compared to placebo on levels of TG in adults with elevated TG and RC.

Timeline

Start
2025-06-30
Primary completion
2026-07
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject MAR001 Unknown — Subcutaneous

Indications

hypertriglyceridemia